Isoimperatorin Inhibits Angiogenesis by Suppressing VEGFR2 Signaling Pathway

ConclusionsOur study showed that isoimperatorin suppressed angiogenesis by targeting the VEGFR2 signaling pathway and could be a potential therapeutic agent for targeting angiogenesis.

Source: Cardiovascular Drugs and Therapy - February 16, 2024 Category: Cardiology Source Type: research